BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 10619721)

  • 1. Immunosuppressive treatment of rippling muscles in patients with myasthenia gravis.
    Müller-Felber W; Ansevin CF; Ricker K; Müller-Jenssen A; Töpfer M; Goebel HH; Pongratz DE
    Neuromuscul Disord; 1999 Dec; 9(8):604-7. PubMed ID: 10619721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rippling muscles and myasthenia gravis with rippling muscles.
    Ansevin CF; Agamanolis DP
    Arch Neurol; 1996 Feb; 53(2):197-9. PubMed ID: 8639072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ocular myasthenia gravis: response to long-term immunosuppressive treatment.
    Sommer N; Sigg B; Melms A; Weller M; Schepelmann K; Herzau V; Dichgans J
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):156-62. PubMed ID: 9048716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease associated with myasthenia gravis. A report of 4 cases.
    Levin N; Karussis D; Abramsky O
    J Neurol; 2003 Jun; 250(6):766-7. PubMed ID: 12862037
    [No Abstract]   [Full Text] [Related]  

  • 5. Acquired rippling muscle disease with myasthenia gravis.
    Greenberg SA
    Muscle Nerve; 2004 Jan; 29(1):143-6. PubMed ID: 14694511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune-mediated rippling muscle disease and myasthenia gravis.
    Bettini M; Gonorazky H; Chaves M; Fulgenzi E; Figueredo A; Christiansen S; Cristiano E; Bertini ES; Rugiero M
    J Neuroimmunol; 2016 Oct; 299():59-61. PubMed ID: 27725122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of myasthenia gravis during pregnancy.
    Bansal R; Goyal MK; Modi M
    Indian J Pharmacol; 2018; 50(6):302-308. PubMed ID: 30783322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decompensating esophoria as the presenting feature of myasthenia gravis.
    Arblaster GE; Shipman TL; Pepper IM
    J AAPOS; 2009 Jun; 13(3):310-1. PubMed ID: 19395293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-mediated rippling muscle disease with myasthenia gravis: a report of seven patients with long-term follow-up in two.
    Schoser B; Jacob S; Hilton-Jones D; Müller-Felber W; Kubisch C; Claus D; Goebel HH; Vita G; Vincent A; Toscano A; Van den Bergh P
    Neuromuscul Disord; 2009 Mar; 19(3):223-8. PubMed ID: 19208478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myasthenia gravis and visceral lupus erythematosus].
    Truniger B
    Schweiz Med Wochenschr; 1979 Dec; 109(47):1847-51. PubMed ID: 394318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brainstem lymphoma in a myasthenia gravis patient on azathioprine.
    Termsarasab P; Katirji B
    J Clin Neurosci; 2015 Feb; 22(2):415-8. PubMed ID: 25443086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presentation of myasthenia gravis mimicking blepharospasm.
    Roberts ME; Steiger MJ; Hart IK
    Neurology; 2002 Jan; 58(1):150-1. PubMed ID: 11781428
    [No Abstract]   [Full Text] [Related]  

  • 13. Isolated Bilateral Triceps Weakness in Myasthenia Gravis.
    Özenç B; Işık K; Odabaşı Z
    Acta Neurol Taiwan; 2024 Jun; 33(2)():73-75. PubMed ID: 37848221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Eaton-Lambert syndrome in ocular myasthenia gravis.
    Oh SJ
    Arch Neurol; 1974 Sep; 31(3):183-6. PubMed ID: 4855164
    [No Abstract]   [Full Text] [Related]  

  • 15. Long term treatment of myasthenia gravis with azathioprine.
    Fonseca V; Havard CW
    Postgrad Med J; 1990 Feb; 66(772):102-5. PubMed ID: 2112245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Problems of postthymectomy-syndromes, e.g. myasthenia gravis (author's transl)].
    Janzen RW; Lachenmayer L; Fischer K
    Med Klin; 1977 Nov; 72(45):1931-7. PubMed ID: 303737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myasthenia gravis and specific immunotherapy: monoclonal antibodies.
    Cai XJ; Li ZW; Xi JY; Song HZ; Liu J; Zhu WH; Guo Y; Jiao Z
    Ann N Y Acad Sci; 2019 Sep; 1452(1):18-33. PubMed ID: 31393614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [On the therapy of muscular diseases].
    Mittelbach F; Bodechtel G
    Munch Med Wochenschr; 1968 Sep; 110(36):1988-93. PubMed ID: 5695705
    [No Abstract]   [Full Text] [Related]  

  • 19. [Myasthenic crisis caused by azathioprine-induced fever].
    Tumani H; George A; Nau R
    Nervenarzt; 1997 Apr; 68(4):336-8. PubMed ID: 9273463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful use of an immune checkpoint inhibitor in a patient with myasthenia gravis in remission.
    Jordan B; Zierz S; Weber T; Jordan K
    Muscle Nerve; 2019 Jul; 60(1):E7-E8. PubMed ID: 31018243
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.